Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DARDAR Health Project
NCT00052195Phase 3Completed
- Sponsor
- Dartmouth Health
- Start
- Sep 2001
- Primary completion
- Dec 2008
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Tuberculosis (TB) comparing Mycobacterium vaccae with Placebo (2 arms). Primary endpoints: Incidence of HIV-associated disseminated tuberculosis, Incidence of HIV-associated pulmonary tuberculosis and 1 more. Started Sep 2001; status: completed.
02
Drugs
mycobacterium vaccae
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00052195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00052195.